Remi Meds logo

Remi Meds Review

5.6
★★★☆☆2.8/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.6/10

Best for: per-dose-tier compounded GLP-1 with named Strive Pharmacy partner

Remi Meds scores below our bar on medical oversight. Read the score breakdown before signing up.

Semaglutide

$249/mo · starting dose

Tirzepatide

$349/mo · starting dose
Price rises with dose

Price checked on Remi Meds' site,

What the monthly price covers

Medication

Included

Provider visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Remi Meds is a DTC compounded-GLP-1 telehealth platform offering per-dose-tier compounded semaglutide and tirzepatide-with-B12, plus NAD+, Sermorelin, and Glutathione add-ons. It names its pharmacy partner (Strive Pharmacy, Gilbert, AZ) and clinical network (Beluga Health), and surfaces full per-tier pricing rather than a floor-only "as low as." Semaglutide runs $249–$369/mo and tirzepatide $349–$639/mo. (Distinct from Remedy Meds.)

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideLegitScript Verified5-Tier Dose PricingDirect-Pay OnlyStrive Pharmacy Partner

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Remi Meds

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Remi Meds logo
2.8 / 5
Our editorial rating
Visit Remi Meds →

from $249/mo · no insurance needed

Remi Meds at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$249/mo (starting dose)
Pricing model
Scales with dose: higher doses cost more
What's included
Medication
FDA status
No FDA warning letter on record

How we scored Remi Meds

Each dimension is scored algorithmically from Remi Meds'published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

4.9/10

Remi Meds' headline is $249 a month at the starting dose. Compare it with other programs on the same plan basis. Note the price scales with dose, so budget for higher tiers as you titrate.

Effectiveness25%

6.8/10

Remi Meds offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

5.8/10

Online intake and platform experience; 7 platform features disclosed.

Trust & Safety15%

5.9/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

4.7/10

Remi Meds' exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

4.5/10

Remi Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Remi Meds review

Last checked October 2026
  • Confirmed current pricing across 4 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$249–$639/mo across 4 dose/plan tiers (checked October 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Remi Meds

We walked Remi Meds' public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Open a treatment page (Personalized GLP-1 or GLP-1/GIP + B12) or the Book Now page.
  2. 2Pick a dose from the price dropdown.
  3. 3Click Start My Free Visit, which opens a 4-step questionnaire.
  4. 4Step 1 asks for your name, sex, date of birth, email and phone.
Price shown before you start
  • Full per-dose pricing is shown before intake: semaglutide $249-$369/mo, tirzepatide + B12 $349-$639/mo.
  • The visit is advertised as free; you pay for medication only if prescribed.
  • Refills aren't auto-charged: you get a monthly renewal notice and pay only if you continue.
  • Submitted orders can't be changed or canceled, and shipped prescriptions are final sale.
  • Some states require a live video or chat visit, plus a photo ID and selfie.
  • Three different phone numbers appear across the site.

Remi Meds customer support

GLP-1 medications Remi Meds offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Peptides Remi Meds offers

Beyond GLP-1s, Remi Meds also offers these peptides. Tap any for our evidence-based guide.

Pricing

Prices re-verified

0.25mg/week starting doseCompounded
$249/mo
semaglutide

$249/mo at 0.25mg. Other tiers: 0.5mg $289, 1mg $329, 1.7mg $345, 2.4mg $369 per month.

2.4mg/week maintenanceCompounded
$369/mo
semaglutide
2.25mg/week starting dose (with B12)Compounded
$349/mo
tirzepatide

$349/mo at 2.25mg. Other tiers: 4.5mg $379, 6.75mg $429, 9mg $549, 11.25mg $639 per month.

11.25mg/week maintenance (with B12)Compounded
$639/mo
tirzepatide

Ready to get started?

Plans and promotions change often, so check Remi Meds' current pricing and active discounts before you decide.

See Remi Meds pricing →

What we like

  • Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ), which most peers don't do
  • LegitScript certification badge on the homepage
  • Publishes 503A FDCA compliance language on the tirzepatide page
  • Per-dose-tier pricing fully shown, not just an 'as low as' floor
  • Operating corporate entity disclosed (T-C Health Co)
  • Does not sell retatrutide, in line with current FDA enforcement
  • Clear non-affiliation disclaimer for Wegovy/Ozempic/Mounjaro trademarks

Watch-outs

  • No named medical director, founder, or physician on any public page
  • States served not listed; the FAQ only says 'nationwide service'
  • Clinical care runs via Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 sellers (Remi itself isn't warned)
  • Orders can't be changed or canceled once submitted, and shipped prescriptions are final sale
  • Three different phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure
  • Mailing address (Leesburg FL) doesn't match the operating-entity state (California)
  • The free-visit form asks for your name, date of birth, email and phone on the first screen

Remi Meds: a transparent price list with a thin paper trail on the people behind it

Remi Meds is a direct-pay, compounded-only GLP-1 telehealth shop that does two things most of its competitors won't. It names the pharmacy that fills your prescription. And it publishes its full per-dose price ladder instead of teasing you with a single 'as low as' floor. That candor is useful when you're shopping. The same site that's upfront about pricing, though, stays quiet about who its medical leadership is, so you are weighing one strong form of transparency against a notable gap in another. If you value seeing the price for the exact dose you'll be on, Remi Meds is worth considering. If you want a named medical director and a clear corporate history, you'll want to read the cautions below first.

How the pricing works: five tiers that climb with your dose

Remi Meds uses a scales-with-dose model, which is a transparent way to price compounded GLP-1s and also the one that can surprise you later. You don't pay one flat rate. Your monthly cost rises as your dose is titrated up. Compounded semaglutide starts at $249 a month at the 0.25 mg starting dose and steps up to the high-three-hundreds at the 2.4 mg maintenance dose. Compounded tirzepatide, which Remi Meds bundles with B12, opens in the mid-three-hundreds and climbs to the low-six-hundreds at the top maintenance tier.

Budget for where you'll end up, not where you start. The starting-dose price is accurate, but most people titrate upward over a few months, and you will spend most of your time in the maintenance tiers. Even so, the entry semaglutide rate sits above the category median of $179 a month, so Remi Meds competes on showing you the whole ladder before you commit rather than on being the cheapest. There's no published teaser or first-month promo rate, so the tiered list is what you pay.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.

The medications and who fills them

Remi Meds sells compounded medication only, with no brand-name Wegovy, Ozempic, Mounjaro or Zepbound, and Remi Meds is careful to post a non-affiliation disclaimer for those trademarks. You get compounded semaglutide and compounded tirzepatide-with-B12 as the core offerings, with NAD+, Sermorelin and Glutathione available as add-ons if you're after the broader wellness menu.

Remi Meds tells you the medication is filled by Strive Pharmacy in Gilbert, Arizona, a specific compounding pharmacy you can look up instead of an anonymous 'licensed partner.' Most compounded-GLP-1 sellers won't give you that name. Pair that with the §503A FDCA compliance language on the tirzepatide page and a LegitScript badge on the homepage, and you have more of a traceable supply chain than the average direct-pay compounder offers.

No retatrutide on the menu

The site does not sell retatrutide, the experimental triple-agonist that the FDA moved against in September 2025. Plenty of compounding sellers kept pushing it anyway. A provider that declines to stock a molecule regulators are actively warning about is showing the kind of restraint you want from a company handling prescription injectables. It's a green flag in an industry that has plenty of red ones.

What gives us pause

For all its pricing candor, Remi Meds is opaque about who runs your care. No medical director, founder, or physician is named anywhere on the public site. By contrast, Spry puts its three co-founders' names on the page and asks for no contract, though it also shows an 'FDA Approved' badge that doesn't apply to compounded drugs. The states it serves aren't listed; the site makes a blanket 'nationwide' claim with no per-state detail. And the corporate footprint is a little mismatched. The operating entity is T-C Health Co, organized in California, but the mailing address is in Leesburg, Florida. A secondary 'Rekindle RX' email and three different phone numbers across the site hint at shared back-office infrastructure that isn't explained.

  • No named clinician or leadership: you can't see who's overseeing your care or running the company.
  • Clinical care runs through Beluga Health, a physician network a 2026 StatNews analysis tied to a large share of FDA-warned GLP-1 telehealth companies. Remi Meds itself has no FDA warning letter, but you should know about the network-level association.
  • Direct-pay only: no insurance is accepted, and shipped prescriptions are final sale, so there's no money-back cushion if it isn't a fit. A submitted order can't be changed or canceled either. Refills aren't auto-charged, though: you get a monthly renewal notice and pay only if you continue.
  • Year founded and corporate history are unclear, which makes it hard to judge track record.

Trust and safety: solid on paper, thin on people

Remi Meds clears several safety bars. The pharmacy is named. The LegitScript badge is present. The §503A language is posted. And there's no FDA warning letter against Remi Meds or T-C Health Co. Don't confuse this company with Remedy Meds, a separate brand that did receive an FDA warning letter. Remi Meds is a different corporate entity with a clean letter record. Still, the missing medical leadership, the unenumerated state list, and the Beluga network association keep it out of the top tier. Our scoring methodology weighs disclosed oversight heavily, and that's where Remi Meds loses points.

Who should choose Remi Meds, and who should skip it

Choose it if you're a confident self-pay shopper who wants to see the per-dose price up front, values knowing the filling pharmacy by name, and prefers a seller that steers clear of the molecules regulators are chasing. Skip it if you need insurance billing, want a named physician or medical director you can vet, require a clear list of the states served before you'll enter payment details, or want any refund protection beyond 'all sales final.'

Bottom line

Remi Meds is a better-than-average compounded-GLP-1 platform on the dimensions it chooses to be transparent about (pricing, pharmacy, and regulatory restraint) and noticeably thin on the ones it doesn't: named medical oversight and corporate clarity. The full price ladder and the Strive Pharmacy disclosure give you reasons to pick it over a floor-only competitor. Just go in clear-eyed: confirm the dose you'll ultimately need (and its price), accept that there's no insurance path or refund, and decide whether a platform with no named clinician meets your bar for a long-term medication you'll inject every week. Patients who want a fuller workup first can look at Tonik Wellness, which requires lab work and a provider call before prescribing. Its catch is a three-month minimum on every plan.

The Bottom Line

Remi Meds scores below our bar on medical oversight. Read the score breakdown before signing up.

Score: 5.6/10Best for: per-dose-tier compounded GLP-1 with named Strive Pharmacy partnerFrom: $249 a month at the starting dose

Ready to start with Remi Meds?

From $249 a month at the starting dose. See current pricing and start your online intake.

Remi Meds might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want a brand-name GLP-1 such as Wegovy or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare Remi Meds vs…

Remi Meds scores5.6/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Remi Meds is a direct-to-consumer compounded-GLP-1 telehealth platform offering compounded semaglutide and tirzepatide-with-B12, plus NAD+, Sermorelin, and Glutathione add-ons. It is a distinct brand from Remedy Meds.
Remi Meds shows full per-dose-tier pricing rather than a floor-only as low as figure: compounded semaglutide runs about $249 to $369 per month and tirzepatide about $349 to $639 per month, with the price scaling as your dose increases.
No. Compounded semaglutide and tirzepatide are not FDA-approved products, and its tirzepatide page includes 503A compliance language. Remi Meds does not sell retatrutide, and a licensed clinician determines whether GLP-1 therapy is appropriate for you.
Remi Meds names its compounding pharmacy partner, Strive Pharmacy of Gilbert, Arizona, and states that clinical care runs through independent physician networks including Beluga Health. Beluga Health is a network that a 2026 StatNews analysis associated with many FDA-warned GLP-1 companies, though Remi Meds itself has not received an FDA warning letter.
Remi Meds is direct-pay and does not accept insurance. Prescription orders can't be changed or canceled once submitted and are final sale once shipped. Refills aren't charged automatically; you get a monthly renewal notice and pay only if you continue. It displays a LegitScript Certified seal.
Remi Meds makes a nationwide service claim but does not publish a per-state availability list, so confirm coverage for your state before ordering. No named medical director, founder, or physician is disclosed on its public pages, and its operating entity is T-C Health Co.
Remi Meds doesn't use public promo or coupon codes. Third-party sites advertising "Remi Meds discount codes" are typically fake; any current offer applies automatically through the link on this page.
Remi Meds is an operating telehealth provider, and we found no FDA warning letter on file for it. On its public pages, it shows LegitScript certification. We last checked its prices and policies on its own site in October 2026. We scored it 5.6/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Remi Meds. The concerns our review flags: No named medical director, founder, or physician on any public page; states served not listed; the FAQ only says 'nationwide service'; clinical care runs via Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 sellers (Remi itself isn't warned); orders can't be changed or canceled once submitted, and shipped prescriptions are final sale. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Remi Meds review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Remi Meds' current pricing

Plans from $249 a month at the starting dose. Start the online intake to check eligibility and today's price.